Today: 22 May 2026
Nike stock dips despite NikeSKIMS shoe reveal with Kim Kardashian — what investors watch next
15 January 2026
1 min read

Nike stock dips despite NikeSKIMS shoe reveal with Kim Kardashian — what investors watch next

New York, Jan 14, 2026, 21:24 ET — Market closed

  • Nike shares closed down 1.1% on Wednesday, tracking a weaker U.S. session.
  • Nike said NikeSKIMS will debut its first footwear style, the Rift Mesh, later this month in North America.
  • Traders are watching whether new women’s product launches can translate into steadier demand and better margins.

Nike shares closed down 1.1% on Wednesday, even as the company rolled out details for its first NikeSKIMS shoe, due to hit North America on Jan. 26. “The Rift isn’t just a shoe — it’s a 90s icon,” Kim Kardashian said. About Nike

The timing matters because Nike is leaning harder on new product and partnerships to shake off a choppy turnaround story. Investors have been looking for signs that demand is stabilizing without deeper discounting, and that the brand still has pull with consumers paying full price.

NikeSKIMS is one of the clearer bets on women’s growth, a market where Nike has been trying to catch up after rivals built faster momentum. “The women’s business has faster growth,” Morningstar analyst David Swartz said when the partnership was announced. Reuters

Broader markets did not help on Wednesday. The S&P 500 fell 0.53% and the Dow slipped 0.09%, while Nike ended at $65.57 and remained more than 20% below its 52-week high; volume was also light versus its recent average.

Some bulls have been trying to frame the current stretch as a setup trade into 2026. Jefferies analyst Randal Konik recently called Nike his top large-cap pick for the year and urged investors to “buy shares aggressively,” according to Barron’s. Barron’s

Nike is still fighting to win back market share it ceded to newer brands, while also spending more to refresh demand. The company has been clearing older inventory and leaning into a larger marketing push, and has flagged competition from names such as On and Deckers’ Hoka.

But the near-term math remains tight. Nike’s margins have been under pressure from discounting and a shift in sales mix, and the company has warned that tariffs remain a headwind; China has also been a sore spot. “It is a concern that the China results continue to be so poor,” Swartz said after Nike’s last quarterly report. Reuters

That is the risk case into the next session: the NikeSKIMS launch draws attention but does not move the revenue needle fast enough, while promotions, tariffs and a slow China recovery keep squeezing profits. Any stumble in wholesale orders or digital demand could pull the stock back toward recent lows.

For the week ahead, traders will focus on follow-through from the NikeSKIMS announcement, any fresh analyst calls, and signals on U.S. consumer demand after a soft tape for discretionary names. The next hard catalyst is Nike’s next quarterly report, which has not been confirmed by the company; Wall Street earnings calendars estimate a mid-March release, around March 19.

Stock Market Today

  • FTSE 100 Edges Higher as AstraZeneca Gains Oncology Drug Approvals
    May 22, 2026, 12:20 PM EDT. London's FTSE 100 closed the week up 0.22% amid mixed economic data. UK retail sales dropped 1.3% in April, missing expectations, reflecting early impact from the Middle East conflict on consumer spending. UK borrowing also exceeded forecasts, reaching 24.3 billion pounds. Consumer confidence improved slightly, rising two points to -23 in May according to GfK, but uncertainty remains over inflation and interest rates. On the corporate front, AstraZeneca shares dipped 0.64% after receiving European Union recommendations for approval of its oncology drugs camizestrant and Enhertu, while its partner Daiichi Sankyo's Datroway won FDA approval for treating metastatic breast cancer. These developments mark progression in AstraZeneca's cancer therapy portfolio amid cautious market sentiment.

Latest articles

Navitas Stock Up Again as Market Looks at AI Power Trade

Navitas Stock Up Again as Market Looks at AI Power Trade

22 May 2026
Navitas Semiconductor shares jumped 16.33% to $28.36 on Friday, following an 18.32% surge Wednesday ahead of its PCIM 2026 showcase. The company reported Q1 revenue of $8.6 million, up 18% from the prior quarter but down from $14 million a year ago. Navitas plans to demonstrate new high-efficiency power boards for AI data centers. Analysts say breakeven may require quarterly sales above $30 million.
Qualcomm Shares Surge 13% After Stellantis Deal Announced

Qualcomm Shares Surge 13% After Stellantis Deal Announced

22 May 2026
Qualcomm shares jumped 12.7% to $240.44 after Stellantis expanded a multi-year deal to use Snapdragon chips in cockpit, connectivity, and driver-assistance systems. The agreement includes the Ride Pilot platform for Level 2+ hands-free driving. Analysts remain divided, with price targets ranging from $150 to $300 and a broad Hold consensus. Qualcomm reported record automotive chip revenue and 20% growth in automotive and IoT segments.
Dutch Regulator Targets Gas Bill Fine Print, Consumers Caught Off Guard

Dutch Regulator Targets Gas Bill Fine Print, Consumers Caught Off Guard

22 May 2026
Dutch regulator ACM has barred energy suppliers from raising prices mid-term on fixed gas contracts to cover future green-gas and EU carbon costs. Budget Thuis, Delta Energie, Innova Energie, Mega, and Vattenfall had clauses allowing such increases, with potential annual extras up to €326 for some households. The EU’s ETS2 carbon market and Dutch green-gas rules take effect from 2027 and 2028.
EchoStar Corporation (SATS) stock jumps nearly 6% as Dish vendor dispute hits FCC SpaceX review
Previous Story

EchoStar Corporation (SATS) stock jumps nearly 6% as Dish vendor dispute hits FCC SpaceX review

Fortescue Ltd stock ends higher after Zitara deal — what FMG investors watch next week
Next Story

Fortescue Ltd stock ends higher after Zitara deal — what FMG investors watch next week

Go toTop